CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Mycophenolate mofetil as second line therapy in Autoimmune Hepatitis?
DOI 10.1055/s-2008-1037665
Bibliografische Angaben
Nachweis in CareLit
Autor:innenEM Hennes, YH Oo, C Schramm, U Denzer, P Buggisch, C Wiegard, S Kanzler, M Schuchmann, WO Böcher, PR Galle, DH Adams, AW Lohse
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: In patients with autoimmune hepatitis efficient immunosuppressive therapy is essential to avoid progression to cirrhosis. There is no established second line therapy for patients failing standard therapy with steroids and azathioprine. The aim of this study was to examine the possible role of Mycophenolate mofetil (MMF) as second line treatment of autoimmune hepatitis (AIH). Patients and methods: We we…
Zitieren
Zitierempfehlung
EM Hennes, YH Oo, C Schramm, U Denzer, P Buggisch, C Wiegard, S Kanzler, M Schuchmann, WO Böcher, PR Galle, DH Adams, AW Lohse (2008) Mycophenolate mofetil as second line therapy in Autoimmune Hepatitis?. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-2008-1037665
Mit CareLit weiterarbeiten